Differential regulation on human skin fibroblast by α1 adrenergic receptor subtypes

Biochemical Pharmacology

Volumn 74, Issue 9, 2007, Pages 1401-1412

  Sterin Borda, Leonor ^a,b   Furlan, César ^a   Orman, Betina ^a   Borda, Enri ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

1 Adrenergic subtypes; Binding of 3H prazosin; Cyclic AMP; Human fibroblast; Phosphoinositides; Skin fibroblast

Indexed keywords

5 METHYLURAPIDIL; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ADENYLATE CYCLASE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; ATROPINE; CALMODULIN; CYCLIC AMP; NITRIC OXIDE SYNTHASE; OXYMETAZOLINE; PHENYLEPHRINE; PHOSPHATIDYLINOSITIDE; PHOSPHOLIPASE C; PRAZOSIN; RADIOLIGAND; RECEPTOR SUBUNIT; SILODOSIN; THYMIDINE; YOHIMBINE;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG BINDING; DRUG INHIBITION; DRUG RECEPTOR BINDING; ENZYME INHIBITION; HUMAN; HUMAN CELL; NEWBORN; PRIORITY JOURNAL; RADIOASSAY; SKIN FIBROBLAST;

ADRENERGIC AGONISTS; ADRENERGIC ANTAGONISTS; BINDING, COMPETITIVE; CELL CULTURE TECHNIQUES; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; CYCLIC AMP; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; HUMANS; INOSITOL PHOSPHATES; NITRIC OXIDE SYNTHASE; RADIOLIGAND ASSAY; RECEPTORS, ADRENERGIC, ALPHA-1; THYMIDINE;

EID: 34548847775     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2007.06.041     Document Type: Article

References (40)

1. Graham R.M., Perez D.M., Haw J., and Piacik M.T. Alpha 1 adrenergic receptor subtypes. Molecular structure function and signalling. Circ Res 78 (1996) 737-749
2. Hieble J.P., Bylund D.B., Clarke D.E., Eikenburg D.C., Langer S.Z., Lefkowitz R.J., et al. International union of pharmacology. Recommendation for nomenclature of alpha 1-adrenoceptors consensus update. Pharmacol Rev 47 (1995) 267-270
3. 1B-adrenergic receptor. J Biol Chem 267 (1992) 21936-21945
4. Hirasawa A., Horie K., Tanaka T., Takagaki K., Mural M., Yano J., et al. Cloning, functional expression and tissue distribution of human cdna for the alpha 1c-adrenergic receptor. Biochem Biophys Res Commun 195 (1993) 902-909
5. Esbenshade T.A., Hirasawa A., Tsujimoto G., Tanaka T., Yano J., Minneman K.P., et al. Cloning of the human alpha 1d-adrenergic receptor and inducible expression of three human subtypes in sknmc cells. Mol Pharmacol 47 (1995) 591-598
6. Price D.T., Lefkowitz R.J., Caron M.G., Berkowitz D., and Schwinn D.A. Localization of mRNA for three distinct alpha 1-adrenergic receptor subtypes in human tissues. Implication for human alpha-adrenergic physiology. Mol Pharmacol 45 (1994) 171-175
7. Goetz A.S., King H.K., Ward S.D.C., True T.A., Rimele T.J., and Saussy Jr. D.L. BMY 7378 is a selective antagonist of the d subtype of alpha 1-adrenoceptor. Eur J Pharmacol 272 (1995) R5-R6
8. Perez D.M., Piascik M.T., and Graham R.M. Solution-phase library screening for the identification of rare clones: isolation of alpha 1 D adrenergic receptor cDNA. Mol Pharmacol 40 (1991) 876-883
9. 1-adrenergic receptor subtype. Endocrinology 145 (2004) 5157-5167
10. Faber J.E., Yang N., and Xin X. Expression of α adrenoceptors subtypes by smooth muscle cells and adventitial fibroblasts in rat aorta and in cell culture. J Pharmacol Exp Ther 298 (2001) 441-452
11. Waldrop B.A., Mastalerz D., Piascik M.T., and Post G.R. Alpha 1 B and alpha 1 D adrenergic receptors exhibit different requirements for agonist and mitogen-activated protein kinase activation to regulate growth responses in rat 1 fibroblasts. J Pharm Exp Ther 300 (2002) 83-90
12. Davis R.J. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 268 (1993) 14553-14556
13. García-Sáinz J.A., Rodríguez-Peréz E., and Romero-Ávila T. Human α1D-adrenoceptor phosphorylation and desensitization. Biochem Pharmacol 67 (2004) 1853-1858
14. Solomonssonm S., Oker M., Kim S., Zhang H., Faber J.E., and Arendshorst W.J. Alpha 1 adrenoceptor subtypes on rat afferent arterioles assessed by radioligand binding and RT-PCR. Am J Physiol Renal Physiol 281 (2001) F172-F178
15. Minneman K.P. Alpha 1-adrenergic receptor subtypes, inositol phosphates and sources of cell calcium. Pharmacol Rev 40 (1988) 87-119
16. Crespo P., Cachero P.G., Xu N., and Gutkin J.S. Dual effect of beta adrenergic receptors on mitogen-activated protein kinase. Evidence for a beta gamma-dependent activation and alpha s-camp-mediated inhibition. J Biol Chem 270 (1995) 25259-25265
17. Dikic I., Tokiwa G., Lev S., Courtneidge S., and Schlessinger J. A role for pik2 and src in linking g-protein-coupled receptors with MAP kinase activation. Nature 383 (1996) 547-550
18. Varani J., Mitra R.S., Gibbs D., Phan S.H., Dixit D.M., Mitra R.J., et al. All-trans retinoic acid stimulates growth an extracellular matrix production in growth-inhibited cultured human skin fibroblasts. J Invest Dermatol 94 (1990) 717-723
19. Busch L., and Borda E. Castration decreases amylase release associated with muscarinic acetylcholine receptor downregulation in rat parotid gland. Br J Pharmacol 139 (2003) 399-407
20. Borda T., Genaro A., Sterin-Borda L., and Cremaschi G. Involvement of endogenous nitric oxide signaling system in brain muscarinic acetylcholine receptor activation. J Neural Transm 105 (1998) 193-204
21. Hokin-Neaverson M., and Sadeghian K. Separation of 3H-inositol monophosphates and 3H-inositol on silica gel glass-fiber sheets. J Chromatogr 120 (1976) 502-505
22. Bredt D.S., and Synder S.H. Nitric oxide mediates glutamante-linked enhancement of cyclic GMP levels in the cerebellum. Proc Natl Acad Sci USA 86 (1999) 9030-9033
23. Michel M.C., Kenny B., and Schwinn D.A. Classification of alpha 1-adrenoceptor subtypes. Naunyn Schmiedebergs Arch Pharmacol 352 (1995) 1-10
24. To) in rat ventricular myocytes. Br J Pharmacol 129 (2000) 1113-1120
25. Chang D.J., Chang T.K., Yaminishi S.S., Salazar F.H.R., Kosaka A.H., Khare L., et al. Molecular cloning, genomic characterization and expression of novel human alpha1A-adrenoceptor isoforms. FEBS Lett 422 (1998) 279-283
26. Tseng-Crank J., Kost T., Goetz A., Hazum S., Roberson K.M., Haizlip J., et al. The alpha 1C-adrenoceptor in human prostate: cloning, functional expression, and localization to specific prostatic cell types. Br J Pharmacol 115 (1995) 1475-1485
27. 1A-adrenoceptors. Biochem J 343 (1999) 231-239
28. Han C., Li J., and Minneman K.P. Subtypes of alpha 1-R in rat blood vessels. Eur J Pharmacol 190 (1990) 97-104
29. Zilles K., Gorss G., Schleider A., Schildgen S., Bauer A., Bahro M., et al. Regional and laminar distributions of alpha 1-AR and their subtypes in human and rat hippocampus. Neuroscience 40 (1991) 307-320
30. Xiao L., and Jeffries W.B. Kinetics of alkylation of cloned rat alpha 1 adrenoceptor subtypes by chloroethylclonidine. Eur J Pharmacol 347 (1998) 319-327
31. MacLennan S.J., Reynen P.H., Martin R.S., Eglen R.M., and Martin G.R. Characterization of human recombinant alpha 2A adrenoceptors expressed Chinese Hamster lung cells using extracellular acidification rate changes. Br J Pharmacol 129 (2000) 1333-1338
32. Long C.S., Hartogenesis W.E., and Simpson P.C. Beta adrenergic stimulation of cardiac non-myocytes augments the growth-promoting activity of non-myocyte conditioned medium. J Mol Cell Cardiol 25 (1993) 915-925
33. Dubey R.K., Gillespie D.G., Mi Z., and Jackson E.K. Endogenous cyclic AMP-adenosine pathway regulates cardiac fibroblast growth. Hypertension 37 (2001) 1095-1100
34. Marienfeld U., Walter U., and Simm A. Inhibition of rat cardiac fibroblast growth by cAMP but not by cGMP-dependent protein kinase. Basic Res Cardiol 96 (2001) 184-191
35. Leicht M., Greipel N., and Zimmer H.G. Comitogenic effect of catecholamines on rat cardiac fibroblasts in culture. Cardiovasc Res 48 (2000) 274-284
36. Pupo A.S., and Minneman K.P. Interaction of neuronal nitric oxide synthase with alpha 1 adrenergic receptor subtype in transfected HEK-293 cells. BMC Pharmacol 2 (2002) 1-7
37. Hirasawa A., Sugawara T., Awaji T., Tsamaya K., Ito H., and Tsujimoto G. Subtype-specific differences in subcellular localization of alpha 1-adrenoceptors: chlorethylclonidine preferentially alkylates the accessible cell surface alpha 1-adrenocerptors irrespective of the subtype. Mol Pharmacol 52 (1997) 764-770
38. Bleasdale J.D., Thakur N.R., Grimban R.S., Bundy G.L., Fitzpatrick F.A., Smith R.J., et al. Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils. J Pharmacol Exp Ther 255 (1990) 756-768
39. Scharff O., and Foder B. Effect of trifluoroperazine (TFP) and verapamil on the rate of calmodulin binding to erythrocyte calcium ATPase. Biochem Byophys Acta 772 (1984) 29-36
40. G-nitro-l-arginine impairs nitric oxide synthase from l-arginine. Naunyn Schmiedeberg Arch Pharmacol 347 (1990) 143-147